<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "riTUXimab inj VIAL">
<dose><value>1000</value>
<value>375</value>
<value>500</value>
<value>50</value>
<value>325</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>riTUXimab inj VIAL</value>
</drugname><strength><value>10 mg/mL</value>
</strength><frequency><value>EVERY 2 WEEKS</value>
<value>WEEKLY</value>
<value>ONCE</value>
</frequency><instruction><value>for 2 doses.</value>
<value>for 4 doses.</value>
<value>Administer dose diluted in 250 mL sodium chloride 0.9% over 2 hours. (If the first or previous infusion were well tolerate, administer the first 35 mL over 35 minutes and if well tolerated, give the remaining contents of the dose over 90 minutes).</value>
<value>DOSE 1 of 2. (Total dose split into 2 doses: 50mg/m2 and 325 mg/m2).</value>
<value>DOSE 2 of 2. (Total dose split into 2 doses: 50mg/m2 and 325 mg/m2).</value>
<value>Administer dose diluted in 250 mL sodium chlordie 0.9%. Start infusion at 50 mg/mL and increase by 50 mg/hours every 30 minutes to a maximum of 400 mg/hour if tolerated.</value>
<value>for 4 doses. Administer dose diluted in 250 mL sodium chloride 0.9% over 2 hours. (If the first or previous infusion were well tolerate, administer the first 35 mL over 35 minutes and if well tolerated, give the remaining contents of the dose over 90 minutes).</value>
</instruction><volume><value>10 mL</value>
<value>50 mL</value>
</volume><units><value>mg</value>
<value>mg/m2</value>
</units><additionalnotes><value>Rheumatoid Arthritis</value>
<value>Vasculitis</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn></indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3315</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose></maximumprndose><din><value>02241927</value>
</din></drug>